{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:38:02Z","timestamp":1792723082502,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.yexcr.2026.115173","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:42:59Z","timestamp":1790095379000},"page":"115173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Matrine induces aggressive prostate cancer cell death via inhibition of PPAR\u03b1 activity: insights from transcriptomics, molecular docking, and functional studies"],"prefix":"10.1016","volume":"463","author":[{"given":"Xiuchen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2226-0252","authenticated-orcid":false,"given":"Yulong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yexcr.2026.115173_bib1","first-page":"485","article-title":"Prostate cancer statistics, 2025","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115173_bib2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s11864-024-01215-2","article-title":"Metastatic castration-resistant prostate cancer: advances in treatment and symptom management","volume":"25","author":"Kulasegaran","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"issue":"17","key":"10.1016\/j.yexcr.2026.115173_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.yexcr.2026.115173_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2021.100034","article-title":"Prostate cancer: therapeutic prospect with herbal medicine","volume":"2","author":"Ghosh","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115173_bib5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pros.23317","article-title":"A placebo-controlled double-blinded randomized pilot study of combination phytotherapy in biochemically recurrent prostate cancer","volume":"77","author":"van Die","year":"2017","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.yexcr.2026.115173_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.urolonc.2024.12.260","article-title":"Harnessing nature's therapeutic potential: a review of natural products in prostate cancer management","volume":"43","author":"Metri","year":"2025","journal-title":"Urol. Oncol."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115173_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12032-023-02209-0","article-title":"A holistic approach to prostate cancer treatment: natural products as enhancers to a medically minded approach","volume":"40","author":"Stokes","year":"2023","journal-title":"Med. Oncol. (Northwood)"},{"key":"10.1016\/j.yexcr.2026.115173_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.963317","article-title":"Synergistic effects of natural products in combination with anticancer agents in prostate cancer: a scoping review","volume":"13","author":"Cheon","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115173_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156405","article-title":"Modified shenqi Dihuang decoction inhibits prostate cancer metastasis by disrupting TCA cycle energy metabolism via NF-kB\/p65-mediated OGDH regulation","volume":"138","author":"Zhang","year":"2025","journal-title":"Phytomedicine : international journal of phytotherapy and phytopharmacology"},{"issue":"1","key":"10.1016\/j.yexcr.2026.115173_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1186\/s40001-023-01477-w","article-title":"PPARG is a potential target of tanshinone IIA in prostate cancer treatment: a combination study of molecular docking and dynamic simulation based on transcriptomic bioinformatics","volume":"28","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"7","key":"10.1016\/j.yexcr.2026.115173_bib11","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.21037\/tau-24-49","article-title":"A review of tanshinone compounds in prostate cancer treatment","volume":"13","author":"Ji","year":"2024","journal-title":"Transl. Androl. Urol."},{"issue":"21","key":"10.1016\/j.yexcr.2026.115173_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110347","article-title":"Xanthohumol triggers pyroptotic in prostate cancer cells via the Caspase-3\/GSDME signaling pathway","volume":"26","author":"Sun","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115173_bib13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3389\/fphar.2020.00588","article-title":"Matrine: a promising natural product with various pharmacological activities","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115173_bib14","doi-asserted-by":"crossref","first-page":"10125","DOI":"10.2147\/CMAR.S213419","article-title":"The effects of matrine in combination with docetaxel on castration-resistant (Androgen-Independent) prostate cancer","volume":"11","author":"Li","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115173_bib15","first-page":"945","article-title":"Matrine inhibits prostate cancer via activation of the unfolded protein response\/endoplasmic reticulum stress signaling and reversal of epithelial to mesenchymal transition","volume":"18","author":"Chang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yexcr.2026.115173_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.freeradbiomed.2024.05.030","article-title":"Oxidative stress in peroxisomes induced by androgen receptor inhibition through peroxisome proliferator-activated receptor promotes enzalutamide resistance in prostate cancer","volume":"221","author":"Shiota","year":"2024","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2026.115173_bib17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clnu.2023.12.005","article-title":"Peroxisome proliferator-activated receptors: a key link between lipid metabolism and cancer progression","volume":"43","author":"Li","year":"2024","journal-title":"Clin. Nutr. (Edinb.)"},{"key":"10.1016\/j.yexcr.2026.115173_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.intimp.2017.08.027","article-title":"The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells","volume":"52","author":"Usui-Ouchi","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115173_bib19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s12276-025-01420-5","article-title":"LncRNA Gm35585 transcriptionally activates the peroxidase EHHADH against diet-induced fatty liver","volume":"57","author":"Jin","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"12","key":"10.1016\/j.yexcr.2026.115173_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121623","article-title":"Vascular PPAR\u03b2\/\u03b4 promotes tumor angiogenesis and progression","volume":"8","author":"Wagner","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.yexcr.2026.115173_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jnc.13152","article-title":"Rosiglitazone-activated PPAR\u03b3 induces neurotrophic factor-\u03b11 transcription contributing to neuroprotection","volume":"134","author":"Thouennon","year":"2015","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.yexcr.2026.115173_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update","volume":"87","author":"Schafer","year":"2025","journal-title":"Eur. Urol."},{"issue":"20","key":"10.1016\/j.yexcr.2026.115173_bib23","first-page":"1698","article-title":"Prostate cancer cases might rise to 3 million globally by 2040","volume":"331","author":"Harris","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2026.115173_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.932510","article-title":"Prostate cancer cells of increasing metastatic potential exhibit diverse contractile forces, cell stiffness, and motility in a microenvironment stiffness-dependent manner","volume":"10","author":"Molter","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"15","key":"10.1016\/j.yexcr.2026.115173_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152432","article-title":"Peroxisome proliferator-activated receptors and the hallmarks of cancer","volume":"11","author":"Wagner","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2026.115173_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102039","article-title":"Peroxisome proliferator-activated receptors: key regulators of tumor progression and growth","volume":"47","author":"Asgharzadeh","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.yexcr.2026.115173_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176304","article-title":"Roles of PPAR activation in cancer therapeutic resistance: implications for combination therapy and drug development","volume":"964","author":"Zhang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.yexcr.2026.115173_bib28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/s41467-025-56675-3","article-title":"PPAR\u03b1-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma","volume":"16","author":"Van den Bossche","year":"2025","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.yexcr.2026.115173_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26189132","article-title":"Reprogrammed lipid metabolism-associated therapeutic vulnerabilities in prostate cancer","volume":"26","author":"Parupathi","year":"2025","journal-title":"Int. J. Mol. Sci."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:51:40Z","timestamp":1792720300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726002909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0014482726002909"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115173","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Matrine induces aggressive prostate cancer cell death via inhibition of PPAR\u03b1 activity: insights from transcriptomics, molecular docking, and functional studies","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115173"}}